KBC Securities - EKOPAK NV (EKOP) ... Morning Notes : FAGR BB, EKOP BB, ZEAL DC

Report

KBC Securities

Hilde Van Boxstael ...

Jacob Mekhael
Kristof Samoy
Mathijs Geerts Danau
Wim Lewi

Morning Notes : FAGR BB, EKOP BB, ZEAL DC

: FAGR BB, EKOP BB, ZEAL DC

05/02/2026 1 EN

Underlyings

EKOPAK NV

See profile

BE0974380124 Euronext Brussels Belgium

Fagron SA

Fagron supplies products, services to professionals and institutions in the healthcare sector in Europe, the U.S.A. and Brazil. Co.'s activities are subdivided into four divisions. Through Fagron, Co. offers products and concepts for pharmaceutical compounding. Through Arseus Dental, Co. supplies dental products and concepts to dentists and dental laboratories in Belgium, the Netherlands, France, Germany and Switzerland. Through Arseus Medical, Co. supplies medical and surgical products to specialists, elderly homes, homecare nurses and hospitals in Belgium and the Netherlands. Through Corilus, Co. supplies ICT total solutions for medical specialists in Belgium, the Netherlands and France.

See profile

BE0003874915 Euronext Brussels Belgium

Zealand Pharma A/S

Zealand Pharma is a biotechnology company. Co. is engaged in the discovery development and commercialization of peptide-based medicines. Co.'s pipeline comprises two implementation areas: Cardio-metabolic diseases and Other indications. The Cardio-metabolic diseases area includes medicines for diabetes and obesity treatment, such as Lyxumia (Lixisenatide), Lyxumia/Lantus, ZP2929 and Danegaptide. The Other indications area are ZP1848, Elsiglutide and ZP1480 (ABT-719) drugs for inflammatory bowel disease, chemotherapy-induced diarrhea and acute kidney injury treatment.

See profile

DK0060257814 Pink OTC Markets United States

Provider

KBC Securities

We are a financial services provider for several types of professional clients, each with distinct needs.

See profile

Analysts

Hilde Van Boxstael

Jacob Mekhael

Kristof Samoy

Mathijs Geerts Danau

Wim Lewi

Other Reports on these Companies

KBC Securities

Ekopak Delivery Waterkracht permit and Dutch wastewater plant acquisition

Yesterday evening an article was published in the local Antwerp newspaper GVA. It stated Flemish Minister of the Environment Jo Brouns (CD&V) has granted a permit for the Waterkracht project. As a result, all chemical companies in the Port of Antwerp will use purified wastewater to cool their production processes starting at the end of 2027. Earlier on the target was to start commercial operations early 2027 and this is still reflected in our earnings model. We will overhaul our model once it is clear there has been no appeal against the permit decision (typically 30 days after initial grant o...

5h / 28m 5h / 28m 1 EN

KBC Securities

Zealand Pharma Model update, multiple important catalysts ahead

We update our Zealand model following the company's recent CMD held in December 2025. Zealand outlined its plans to become a generational metabolic health company, as well as sharing clear targets with 5 product launches in the next 5 years, and to have 10+ clinical programs by 2030. Our model update incorporates adjusted milestone timing from Roche, removes dapiglutide, as well as a few small tweaks on the rare disease pipeline. All in all, this brings us to a new TP of DKK 960 (from DKK 1,120). With multiple important catalysts ahead including the highly anticipated phase 2b results for petr...

5h / 45m 5h / 45m 1 EN

Vopak First Reaction - Withdrawal of support by First Nation for REEF terminal

Yesterday, Energynow.ca published an article on the withdrawal of support by the Metlakatla First Nation citizens of Canada. Supposedly the Metlakatla First Nation's decision to retract its backing for the nearly completed REEF export project is rooted in concerns that it was not informed of an exclusivity agreement granting REEF an export monopoly, which could harm its economic interests in the rival Trigon terminal where it holds a 10% stake. A recent BC Supreme Court ruling allowing Metlakatla's damages claim to proceed has strengthened the nation's challenge to the agreement. In the articl...

2h / 5m 2h / 5m 1 EN

Kristof Samoy

Kristof Samoy

Ekopak Delivery Waterkracht permit and Dutch wastewater plant acquisition

5h / 28m 5h / 28m 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Morning Notes : FAGR BB, EKOP BB, ZEAL DC

We are a financial services provider for several types of professional clients, each with distinct needs.

Ekopak Delivery Waterkracht permit and Dutch wastewater plant acquisition

Zealand Pharma Model update, multiple important catalysts ahead

Vopak First Reaction - Withdrawal of support by First Nation for REEF terminal

Ekopak Delivery Waterkracht permit and Dutch wastewater plant acquisition

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe